Support for a non-cell-autonomous mechanism underlying hamartoma formation comes from the demonstration that CLOVES syndrome patients, who also develop hamartomas, have activating mutations in PIK3CA, which phenocopies PTEN loss (Kurek et al., 2012b). The gene discussed is PTEN; the disease is hamartoma.